SILYSTA
ActiveSummary
SILYSTA has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €203,951 and a net result of €68,972. Equity is growing by ~67.8% per year across the filed fiscal years. Its solvency ranks better than 79% of 16754 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency100▲+16
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €18,000 at 30 days acceptable
Liquidity ample (current ratio 4.24 against 1.04 in 2024; short-term debt: 12.7% and cash: 3.2% of total assets), and 12.7% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
87.3%
Return on assets
29.5%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-03-2026, 136 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
136 d early
2024
12 d late
2023
7 d late
2022
24 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 4 accounts on average 23 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 10 August (3 of the last 4 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€203,951▲ 51.1%
2024 · €134,979
Total assets
€233,614▲ 2.9%
2024 · €227,111
Net result
€68,972▼ 2.0%
2024 · €70,384
Working capital
€96,180▲ 3,557%
2024 · €2,630
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line2022202320242025
Operating result€5,530-€79,299▲ 1,334%€94,130▲ 18.7%€91,194▼ 3.1%
Net result€2,655below the sector's middle half-€59,439within the sector's middle half▲ 2,138%€70,384within the sector's middle half▲ 18.4%€68,972within the sector's middle half▼ 2.0%
Equity€5,155below the sector's middle half-€64,595within the sector's middle half▲ 1,153%€134,979within the sector's middle half▲ 109%€203,951within the sector's middle half▲ 51.1%
Total assets€224,075within the sector's middle half-€272,759within the sector's middle half▲ 21.7%€227,111within the sector's middle half▼ 16.7%€233,614within the sector's middle half▲ 2.9%
Debt€218,920-€208,164▼ 4.9%€92,132▼ 55.7%€29,663▼ 67.8%
Working capital-€137,739below the sector's middle half--€83,156below the sector's middle half▲ 39.6%€2,630below the sector's middle half€96,180within the sector's middle half▲ 3,557%
Solvency2.3%below the sector's middle half-23.7%below the sector's middle half▲ 21.4pp59.4%within the sector's middle half▲ 35.8pp87.3%above the sector's middle half▲ 27.9pp
Current ratio0.10below the sector's middle half-0.48below the sector's middle half▲ 0.381.04below the sector's middle half▲ 0.564.24within the sector's middle half▲ 3.20
Return on assets (ROA)1.2%below the sector's middle half-21.8%within the sector's middle half▲ 20.6pp31.0%within the sector's middle half▲ 9.2pp29.5%within the sector's middle half▼ 1.5pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 3% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €233,614
Fixed assets
€107,771 ▼ 33.9%
Current assets
€125,843 ▲ 96.4%
Equity and liabilities €233,614
Equity
€203,951 ▲ 51.1%
Debt
€29,663 ▼ 67.8%
Debt's share of the balance-sheet total falls from 40.6% to 12.7%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€111,533▼
2024 · €129,555
Cash flow
€89,310▼
2024 · €105,809
Debt to equity
0.15▼
2024 · 0.68
ROE
33.8%▼
2024 · 52.1%
Interest coverage
29.00▼
2024 · 40.64
Debt ≤ 1 year
€29,663▼
2024 · €61,429
Debt > 1 year
€0▼
2024 · €30,703
Income taxes
€19,268▼
2024 · €20,601
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 39,276 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 96% are still going.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
1.6%
went bankrupt
2.2%
stopped otherwise
96%
still going
A further 0.5% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 39,276 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €6,438 | €32,224 | €35,425 | €20,339 | ▼ 42.6% |
| Other operating charges640/8 | €535 | €1,167 | €1,076 | €1,027 | ▼ 4.5% |
| Non-recurring operating charges66A | - | €496 | €0 | €625 | - |
| Gross operating margin9900 | €12,504 | €113,186 | €130,631 | €113,185 | ▼ 13.4% |
| Operating profit (loss)9901 | €5,530 | €79,299 | €94,130 | €91,194 | ▼ 3.1% |
| Financial income75/76B | - | - | €44 | €891 | ▲ 1,947% |
| Recurring financial income75 | - | - | €44 | €891 | ▲ 1,947% |
| Financial charges65/66B | €1,033 | €2,321 | €3,188 | €3,846 | ▲ 20.6% |
| Recurring financial charges65 | €1,033 | €2,321 | €3,188 | €3,846 | ▲ 20.6% |
| Profit (loss) for the period before taxes9903 | €4,498 | €76,978 | €90,986 | €88,240 | ▼ 3.0% |
| Income taxes67/77 | €1,842 | €17,539 | €20,601 | €19,268 | ▼ 6.5% |
| Profit (loss) for the period9904 | €2,655 | €59,439 | €70,384 | €68,972 | ▼ 2.0% |
| Profit (loss) for the period to be appropriated9905 | €2,655 | €59,439 | €70,384 | €68,972 | ▼ 2.0% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €224,075 | €272,759 | €227,111 | €233,614 | ▲ 2.9% |
| Fixed assets21/28 | €208,648 | €196,220 | €163,052 | €107,771 | ▼ 33.9% |
| Intangible fixed assets21 | €87,855 | €79,055 | €70,255 | €61,455 | ▼ 12.5% |
| Tangible fixed assets22/27 | €120,792 | €117,164 | €92,797 | €46,316 | ▼ 50.1% |
| Furniture and vehicles24 | €82,356 | €82,577 | €62,060 | €13,113 | ▼ 78.9% |
| Other tangible fixed assets26 | €38,437 | €34,587 | €30,737 | €33,203 | ▲ 8.0% |
| Current assets29/58 | €15,428 | €76,539 | €64,059 | €125,843 | ▲ 96.4% |
| Amounts receivable after more than one year29 | - | - | - | €50,000 | - |
| Other amounts receivable291 | - | - | - | €50,000 | - |
| Amounts receivable within one year40/41 | €10,045 | €17,150 | €14,175 | €10,440 | ▼ 26.3% |
| Trade receivables40 | €10,045 | €17,150 | €14,175 | €10,250 | ▼ 27.7% |
| Other amounts receivable41 | - | - | - | €190 | - |
| Current investments50/53 | - | - | €30 | €7,543 | ▲ 24,649% |
| Cash at bank and in hand54/58 | €3,952 | €33,907 | €17,680 | €7,579 | ▼ 57.1% |
| Deferred charges and accrued income490/1 | €1,430 | €25,483 | €32,174 | €50,280 | ▲ 56.3% |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €224,075 | €272,759 | €227,111 | €233,614 | ▲ 2.9% |
| Equity10/15 | €5,155 | €64,595 | €134,979 | €203,951 | ▲ 51.1% |
| Contributions10/11 | €2,500 | €2,500 | €2,500 | €2,500 | = |
| Profit (loss) carried forward14 | €2,655 | €62,095 | €132,479 | €201,451 | ▲ 52.1% |
| Amounts payable17/49 | €218,920 | €208,164 | €92,132 | €29,663 | ▼ 67.8% |
| Amounts payable after more than one year17 | €65,754 | €48,468 | €30,703 | €0 | ▼ 100% |
| Financial debts170/4 | €65,754 | €48,468 | €30,703 | €0 | ▼ 100% |
| Amounts payable within one year42/48 | €153,166 | €159,695 | €61,429 | €29,663 | ▼ 51.7% |
| Current portion of amounts payable after more than one year42 | €16,827 | €17,285 | €17,766 | €0 | ▼ 100% |
| Financial debts43 | - | - | €482 | €214 | ▼ 55.7% |
| Credit institutions430/8 | - | - | €482 | €214 | ▼ 55.7% |
| Trade debts44 | €7,172 | €5,671 | €6,954 | €5,783 | ▼ 16.8% |
| Suppliers440/4 | €7,172 | €5,671 | €6,954 | €5,783 | ▼ 16.8% |
| Taxes, remuneration and social security45 | €1,842 | €7,539 | €20,588 | €20,588 | = |
| Taxes450/3 | €1,842 | €7,539 | €20,588 | €20,588 | = |
| Other amounts payable47/48 | €127,326 | €129,201 | €15,639 | €3,078 | ▼ 80.3% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €2,655 | €59,439 | €70,384 | €68,972 | ▼ 2.0% |
| + Depreciation and write-downs630 | €6,438 | €32,224 | €35,425 | €20,339 | ▼ 42.6% |
| Operating cash flow (approximation) | €9,094 | €91,664 | €105,809 | €89,310 | ▼ 15.6% |
| Investment in fixed assets (approximation) | - | -€19,796 | -€2,257 | €34,942 | ▲ 1,648% |
| Change in cash | - | €29,954 | -€16,227 | -€10,101 | ▲ 37.8% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
17-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Liquidity quadruplescurrent ratio 4.24
Current ratio from 1.04 to 4.24; short-term debt falls from €61,429 to €29,663.
31-12
Financial
Equity above €200,000Eq €203,951 ▲51.1%
4 profitable years in a row build equity to €203,951.
12-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 12 days late
2024
31-12
Financial
Highest result since 2022net €70,384 ▲18.4%
Operating result €94,130, net result €70,384, both a record.
31-12
Financial
Liquidity doublescurrent ratio 1.04
Current ratio from 0.48 to 1.04; short-term debt falls from €159,695 to €61,429.
31-12
Financial
Equity above €100,000Eq €134,979 ▲109%
3 profitable years in a row build equity to €134,979.
07-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 7 days late
2023
24-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 24 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Meise · 1 establishment unit since 2022
Ground area
739 m²
Building footprint
155 m²
Volume, LiDAR
851 m³
Parcel 23093A0015/00S000, Flanders · tallest building 8.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
SILYSTA
since 20222.334.632.028
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23093A0015/00S000 | Flanders | 739 m² | 1 · 155 m² | 8.0 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR. JEREMY DE BRAUWER
BE 0734.401.153
Zandhoven · Eq €204,001
Dr. Jan Loncke
BE 0771.340.337
Brugge · Eq €203,842
Med & Coach
BE 0735.422.425
Namur · Eq €204,183
NATALIX
BE 0460.793.352
Le Roeulx · Eq €203,677
COIGNE ETIENNE DOKTER
BE 0478.514.559
Ieper · Eq €204,230
Of 16,631 companies in sector 86220 we hold annual accounts for 7,986. 6,743 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded23-08-2022
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
77225Rental and leasing activities
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID
0208:0789889014
Also
9925:BE0789889014
Registered
21-08-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.